Brief: Jupiter Wellness Inc - Completed Recruitment For Its Clinical Trial Of Jw-200 For Treatment Of Actinic Keratosis
Feb 18 (Reuters) - Jupiter Wellness Inc JUPW.O :
* JUPITER WELLNESS INC - COMPLETED RECRUITMENT FOR ITS
CLINICAL
TRIAL OF JW-200 FOR TREATMENT OF ACTINIC KERATOSIS
* JUPITER WELLNESS INC - DATA EXPECTED Q1 2022 ON EFFICACY
OF
JW-200
Source text: [ID: https://bit.ly/3oYt9hq]
Further company coverage: JUPW.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bonk
See all newsBrief: Bonk Inc May Offer Up To $100 Million In Common Stock, Preferred Stock, Warrants, Rights, And Units - SEC Filing
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 03:58 AM
Brief: Bonk, Inc. Reports Q3 Financial Results Emerges Debt-Free With $9 Million In Cash And 1,200% Revenue Growth
Brief: Safety Shot Changes Name To Bonk Inc